Neuland Laboratories

17/07/2025

A glimpse of the Mega Medical camp organized by Neuland’s CSR team at Pashamylaram Village, Telangana.

The camp included general health check-ups, diabetes screening, eye examinations, and doctor consultations. In addition, free generic medicines and prescription glasses were distributed to those in need. 320 villagers from nearby districts benefited from the health camp.

15/07/2025

While Scope 1 and 2 emissions are within a company’s control, Scope 3 emissions—those from upstream and downstream activities—are often the largest and most complex to manage. In pharma, these emissions can account for up to 90% of a company’s total footprint.

At Neuland Labs, we’re addressing this challenge by improving visibility, standardizing data, and engaging suppliers across borders.
https://hubs.la/Q03xcZct0

10/07/2025

Sustainability is no longer optional—it’s a business imperative.

At Neuland Labs, we recognize that the biggest challenge in reducing emissions lies not within our operations, but across our supply chain. These indirect, third-party emissions—known as Scope 3—require a new kind of partnership.

“By emphasizing partnership and education, we’re fostering a culture of continuous improvement—even if it means parting ways with those who don’t align with this vision.”
— Sucheth Davuluri, Vice Chairman & CEO

Read how we’re driving change through collaboration, transparency, and shared ESG goals:
https://hubs.la/Q03wCvLQ0

09/07/2025

Parichay 2025: Bridging Aspirations with Purpose

At Neuland, every new joiner is not just welcomed—they’re embraced as part of our evolving family. Each person brings fresh energy, ideas, and the drive to shape what’s next.
We’re excited to welcome our newest colleagues across diverse roles and backgrounds. Their journey begins with Parichay—Neuland’s onboarding induction program that goes beyond introductions to foster connection, purpose, and belonging.
It’s a space where new joiners engage with peers and leaders, explore our vision, and values. Parichay fosters a sense of belonging and purpose from day one.

Let’s extend a heartfelt welcome to all our new colleagues as they step into the Neuland family.

12/06/2025

That’s a wrap from BOS Basel 2025!

Team Neuland had a great time connecting with innovators, biotech leaders, and partners at BOS Basel. These interactions are a reminder of why we do what we do – enabling science that makes a difference.

A big thank you to everyone who stopped by our booth – we look forward to building meaningful collaborations.

09/06/2025

For our customers, certainty in API delivery means everything. That’s why we’ve built a business continuity system that ensure operational resilience, even in the face of disruption.

Read how we’re safeguarding partner expectations with transparency, consistency, and trust: https://hubs.la/Q03pbHNS0

04/06/2025

Neuland Labs will be at the Peptide Therapeutics Forum 2025 on June 5-6.

Meet our Senior Management personnel, Nicola Giubellina, Vice President, Business Development at Booth No. 2 to discover how our end-to-end peptide CDMO solutions can support your development goals.

Looking forward to insightful conversations and new connections!

03/06/2025

Neuland Labs is aligning its Business Continuity framework with the globally recognized ISO 22301:2019 standard – ensuing structured, scalable, and compliant continuity planning.
It’s not just about meeting standards – it’s about exceeding expectations.

Find out what this means for your supply chain: https://hubs.la/Q03pbHNL0

29/05/2025

Pharmaceutical Outsourcing recently sat down with Sucheth Davuluri, Vice-Chairman & CEO, Neuland Labs, to explore how a resilient supply chain isn’t just a buffer against disruption – but a strategic differentiator in today’s pharma landscape.

Discover Sucheth’s perspective on how CDMOs can embrace this mindset to build robust, future-ready supply chains.
https://hubs.la/Q03pbPtD0

The COVID-19 pandemic highlighted vulnerabilities across the pharmaceutical supply chain, prompting contract development and manufacturing organizations (CDMOs) to reassess their approach to operational continuity. In today’s complex business environment, CDMOs must prioritize supply chain resilie...

27/05/2025

Global disruptions have made one thing clear – resilient supply chains are non-negotiable.

Our latest blog dives into how Neuland Labs is addressing this challenge head-on through a robust Business Continuity Management System and ISO 22301:2019 certification pathway.

Learn how we’re ensuring reliability for the long haul: https://hubs.la/Q03pbCfD0

23/05/2025

We’re headed to BOS Basel 2025!
Join Neuland Labs on June 11-12 in Basel, Switzerland.

As your trusted CDMO Partner, we’re excited to connect, collaborate, and explore how we can help advance your API development journey.
Meet us at Booth No. 51 to discover how our expertise can power your next breakthrough.

22/05/2025

In a recent article for Contract Pharma, Saharsh Davuluri, our Vice-Chairman and Managing Director, shared his insights on pivotal trends defining the CDMO landscape in 2025 and beyond and how CDMOs are responding to these dynamic changes in the global environment.

The article focuses on the growing influence of geopolitical factors on outsourcing decisions, the surge in demand for peptide manufacturing – particularly for GLP-1 and the rise of geographic diversity despite challenges in biotech funding.

Read how these changes are shaping the future of pharma:
https://hubs.la/Q03nKTD-0